Pharma News

FDA Continues Focus on Rare Disease Drug Development, Announces Evidence Principles

Tolerance Bio and ZipCode Bio Announce Strategic R&D Collaboration to Advance Targeted Thymus Therapeutics

Novartis snaps up promising ASCVD asset with Tourmaline acquisition

Ionis Pharmaceuticals To Expedite Development Of Rare Neurological Disease Candidate With FDA Breakthrough Status

Epigenic secures $60m financing to advance preclinical assets

Senhwa Biosciences CX-5461 Secures NCI Support to Advance into MYC-Driven Lymphoma, Driving Cross-Cancer and Global Licensing Value

FDA Grants Breakthrough Therapy Designation to Olomorasib With Pembrolizumab for NSCLC

Clene Inc. announces preclinical data showing CNM-Au8 enhances cellular health in Parkinson’s disease models, supporting further clinical development

Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market

Lupin's Aurangabad-based facility gets two observations from US FDA

Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting

Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting